Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer’s disease

Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular Dementia

(2018) Bob Olsson et al.   JOURNAL OF ALZHEIMERS DISEASE

Evaluation of Visinin-Like Protein 1 Concentrations in the Cerebrospinal Fluid of Patients with Mild Cognitive Impairment as a Dynamic Biomarker of Alzheimer's Disease

(2018) Barbara Mroczko et al.   JOURNAL OF ALZHEIMERS DISEASE

Specific protein biomarker patterns for Alzheimer’s disease: improved diagnostics in progress

(2017) Illana Gozes   EPMA Journal

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

(2016) Niklas Mattsson et al.   EMBO Molecular Medicine

Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer’s Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment

(2016) Mirjana Babić Leko et al.   JOURNAL OF ALZHEIMERS DISEASE

Alzheimer’s Disease: Assessing the Role of Spirochetes, Biofilms, the Immune System, and Amyloid-β with Regard to Potential Treatment and Prevention

(2016) Herbert B. Allen   JOURNAL OF ALZHEIMERS DISEASE

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes

(2015) N K Magdalinou et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Immune attack: the role of inflammation in Alzheimer disease

(2015) Frank L. Heppner et al.   NATURE REVIEWS NEUROSCIENCE

Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort

(2015) Maartje I. Kester et al.   Alzheimers Research & Therapy

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

(2015) Konstantin Hellwig et al.   Alzheimers Research & Therapy

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Cerebrospinal fluid analysis in Alzheimer’s disease: technical issues and future developments

(2014) Simone Lista et al.   JOURNAL OF NEUROLOGY

Neuroimaging and Other Biomarkers for Alzheimer's Disease: The Changing Landscape of Early Detection

(2013) Shannon L. Risacher et al.   Annual Review of Clinical Psychology

CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies

(2013) Xinni Luo et al.   JOURNAL OF NEUROCHEMISTRY

Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease

(2012) Anne M Fagan et al.   Biomarkers in Medicine

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease

(2012) R. Tarawneh et al.   NEUROLOGY

SOD1 in Cerebral Spinal Fluid as a Pharmacodynamic Marker for Antisense Oligonucleotide Therapy

(2012) Leah Winer et al.   JAMA Neurology

Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease

(2011) Rawan Tarawneh et al.   ANNALS OF NEUROLOGY

Cerebrospinal Fluid Microglial Markers in Alzheimer’s Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility

(2011) Niklas Mattsson et al.   NEUROMOLECULAR MEDICINE

Identification and Validation of Novel Cerebrospinal Fluid Biomarkers for Staging Early Alzheimer's Disease

(2011) Richard J. Perrin et al.   PLoS One

YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

(2010) Rebecca Craig-Schapiro et al.   BIOLOGICAL PSYCHIATRY

Neuropathology of Alzheimer's Disease

(2010) Daniel P. Perl   MOUNT SINAI JOURNAL OF MEDICINE

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY